Alpha Cubed Investments, LLC Biogen Inc. Transaction History

Alpha Cubed Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	BUY	$253.3 - $285.89 $203,146 - $229,283	802 New	802 $206,000
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $375 - $446	-2 Reduced 0.1%	2,000 $408,000
Q1 2022 Apr 22, 2022	BUY	$193.77 - $244.14 $387,927 - $488,768	2,002 New	2,002 $422,000
Q4 2018 Jan 29, 2019	SELL	$278.5 - $352.75 $604,902 - $766,173	-2,172 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$293.51 - $383.83 $637,503 - $833,678	2,172 New	2,172 $696,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Cubed Investments, LLC with notifications on news.